PR Newswire
ATLANTA, Aug. 2, 2017
ATLANTA, Aug. 2, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading
medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming
37th Annual Canaccord Genuity Growth Conference on Thursday, August 10, 2017 at the
InterContinental Boston Hotel.
A live webcast of the Company's presentation is scheduled to begin at 10:00 a.m. ET and will
feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive
Officer.
The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90
days on the same website.
About CryoLife
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.
CryoLife markets and sells products in more than 80 countries worldwide. For additional information about CryoLife, visit
our website, www.cryolife.com.
|
Contacts:
|
|
|
|
|
CryoLife
|
The Ruth Group
|
|
D. Ashley
Lee
|
Zack
Kubow
|
|
Executive Vice President, Chief Financial Officer
|
646-536-7020
|
|
and Chief Operating Officer
|
zkubow@theruthgroup.com
|
|
Phone: 770-419-3355
|
|
View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-37th-annual-canaccord-genuity-growth-conference-300497684.html
SOURCE CryoLife, Inc.
